Review of 8th RDKit User Group Meeting
Posted
by Paolo Tosco
on
For a few years now the RDKit UGM has been of the great things about September, together with blackberries and ...
-
-
Designing small molecules to target RNA
Posted by Caroline Low onBackground RNA is undruggable - right? Medicinal chemists have almost entirely focused on protein targets to treat human disease and ...
-
September 2019 newsletter
Posted by Sue Peffer onBehind the scenes of Flare's alchemical Free Energy Calculations Last month, Giovanna Tedesco gave a sneak peek at some of the ...
-
Behind the scenes of Flare’s alchemical Free Energy Calculations
Posted by Max Kuhn onLast month, Giovanna Tedesco gave a sneak peek at some of the new features in the upcoming release of Flare™ ...
-
Highlights from the 20th Joint SCI/RSC Medicinal Chemistry Symposium, Cambridge, UK
Posted by Martin Slater onIn my humble opinion, this meeting is one of the best medicinal chemistry conferences to attend and as usual the ...
-
Spark databases: To update or not to update?
Posted by Susan Henderson onSpark™, your solution for scaffold hopping and R-group exploration, is provided with reagent and fragment databases that are derived from ...
-
Free advice for SMEs on how computational chemistry can advance your project
Posted by Andy Smith onThrough our partnership with the Medicines Discovery Catapult we are offering a limited number of computational chemistry consultancy sessions to ...
-
The value of computational chemistry
Posted by Andy Smith onWith the increasing pressure to drive efficiencies in the drug discovery process, innovative approaches using computational chemistry are delivering proven ...
-
August 2019 newsletter
Posted by Sue Peffer onSneak peek at Flare V3.0 for structure-based design Giovanna Tedesco gives a sneak peek at some of the new functionality in Flare ...
-
Sneak peek at Flare V3: New science and improved results
Posted by Giovanna Tedesco onAs we move closer to the release of Flare™ V3, let’s have a quick look at some interesting new functionality ...
-
Alzheimer’s disease: Modeling current and potential targets
Posted by Andy Smith onBy the time we are 65, one in ten of us will have Alzheimer’s disease. This rises to fifty percent ...
-
Pre-launch insight to Torx™, a new platform for small molecule discovery chemistry
Posted by Sue Peffer onRead full press release